Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine

Trial Profile

Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Dec 2014

At a glance

  • Drugs Venlafaxine (Primary) ; Fluoxetine
  • Indications Major depressive disorder
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 29 Dec 2014 Last checked against ClinicalTrials.gov record.
    • 07 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top